TGA Sciences Announce Collaboration with New Immunoassay Platform Company

MEDFORD, Mass. - July 7, 2014 - PRLog -- Medford, MA, July 3, 2014: TGA Sciences, Inc., a contract research organization (CRO), today announced that they have begun a collaboration with the creators of CyPlex LS, immunoassay testing platform. The new platform developed by CyVek, Inc, a CT-based biotech firm, is transforming immunoassay testing by delivering an advanced, fully automated, multi-analyte bench top immunoassay system that integrates a microfluidic cartridge with a state-of-the-art analyzer. CyPlex’s ability to provide “sample to answer” test results with precision and accuracy in a sealed disposable device makes it broadly applicable across numerous sectors, including clinical applications and routine life sciences research.

TGA Quote:

Michael Settles, President/Founder, TGA Sciences, Inc. said:  “We are very excited with this collaboration to not only assist CyVek, Inc. in optimizing and co-market this new technology but to also have the ability to offer our growing number of clients’ additional services that are applicable to both their R&D efforts and further clinical studies.  The CyPlex LS will add to our current offerings by allowing us to meet our client’s requests for flexibility and quick turn-around times when submitting samples for particular analysis.  We look forward to our new collaboration with CyVek, Inc. and how it will benefit both companies.”

CYVEK QUOTE:

Bill Dubiel, Chief Commercial Officer, CyVek, Inc. said: “We are excited to establish an early relationship with a recognized high quality CRO who was referred to us by one of our Pharmaceutical partners. TGA Sciences, Inc. is a FDA registered and inspected cGMP/ GLP  analytical laboratory and has partnered with us to ensure our software meets 21 CFR Part 11 compliance while we provide them the ability to provide their clients with custom developed assays on our cartridges.”

SUMMARY Statement:

TGA Sciences, Inc. collaborates with the makers of CyPlex LS, a new immunoassay platform, to make sure it addresses the needs of the pre-clinical and translational research marketplace.

ABOUT TGA:

TGA Sciences, Inc. is an FDA / EMA inspected contract research laboratory providing the Pharmaceutical, Biotechnology and Research communities a comprehensive range of laboratory services in support of research and clinical studies.  We offer the client a complete package of customized testing systems utilized in pre-clinical through Phase IV studies, all in compliance with cGLP and cGMP requirements.  For more information about TGA Sciences, Inc., please call 781-393-6910 or visit us on the web at:  www.tgasciences.com

About CyVek

CyVek is a privately funded biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology, CyPlex^TM for performing multi-analyte immunoassays. CyPlex™ is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings.  For more information about CyVek, please call 203-679-0395 or visit us on the web at www.cyplexsystems.com.